Phase 1b study to evaluate MK 0482 for Relapsed/Refractory AML/CMML

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503580-42-00

Acronym

MK-0482-002

Enrollment

Registered

2023-07-05

Start date

2023-05-16

Completion date

2023-12-11

Last updated

2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Active CNS leukemia.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026